The Most Important Thing Life Science Companies Need to Do to Create Valuable Patents
September 6, 2015
Tel Aviv, Israel
BioExecutive Forum
Whether in the medical device or biopharm space, strong patents are a key component of the valuation of most life sciences companies. In this fast-paced seminar, Finnegan partner Gerson Panitch will explore patents from the perspective of investors, partners, and competitors, and will pinpoint one critical common thread that catches their attention and separates strong from weak patents. In the process, we will identify specific steps life sciences companies can take to maximize the value they receive from their patents. For more information or to register, please see the BioExecutive Forum's website.
